This fact is particularly surprising since in these mice, while Nano-PSO exerts an intense beneficial clinical effect, it does not induce any reduction in the age depended accumulation of disease related PrP28, the mayor feature of prion diseases such as genetic CJD49. Here, DDX23 is linked to prion disease.